Aldeyra Therapeutics Provides Update on NS2 Clinical Program By: Benzinga via Benzinga March 02, 2015 at 08:33 AM EST Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases ... Read More >> Related Stocks: Aldeyra Therapeu